ali osman Metintas

Dr. ali osman Metintas

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2021 in Mucosa
Verified
Journal Article
Closed access
PDF file
BABurcu Aydemi̇r
Burcu Aydemi̇r
LSLeyla baykal selçuk
Leyla baykal selçuk
DADeniz aksu arıca
Deniz aksu arıca
AMali osman Metintas
ali osman Metintas
Objective Oral lichen planus (OLP) and oral lichenoid reactions (OLR) may occur secondary to dental procedures. Patch testing with the dental series is a simple diagnostic method that can guide the identification of the relevant allergen. In this study, it was aimed to evaluate the patch test results with dental series in OLP and OLR patients. Methods A retrospective review of the medical records of patients who were clinically and/or histopathologically diagnosed with OLP or OLR and, who underwent dental series patch testing at our dermatology clinic in between January 2015 and January 2021 was performed. Results In total, 36 patients with a diagnosis of OLP (n=14, 38.9%) or OLR (n=22, 61.1% ) were included, 15 of whom (41.7%) had positive patch test results. The mean age at presentation was 54.6 years (range 28-72 years). The duration of the disease was 21.9 (range 1-144 months) months on average. Positive findings on patch tests were approximately three times higher in OLR patients than in OLP patients. Gold(I) sodium thiosulfate dihydrate was the most frequent positive reaction (n=6) detected against. Habits (smoking, alcohol) and comorbidities were not significantly associated with the patch test results. Conclusion Detection of allergens with patch test is a helpful diagnostic method for effective control of the disease in both OLP and OLL patients. We think that the detection of contact allergies with patch testing may guide decisions regarding related changes such as dental restorations.

23 February 2026 in Turkish Journal of Dermatology
Verified
Journal Article
Open access
PDF file
AMali osman Metintas
ali osman Metintas
LSLeyla Baykal Selçuk
Leyla Baykal Selçuk
DADeniz Aksu Arıca
Deniz Aksu Arıca
AFArzu Ferhatosmanoğlu
Arzu Ferhatosmanoğlu
İAİbrahim Etem Arıca
İbrahim Etem Arıca
Contact Sensitization in Atopic Dermatitis Patients with Refractory Dermatitis - Turkish Journal of Dermatology

25 September 2026
Verified
Book Chapter
Closed access
AMali osman Metintas
ali osman Metintas
Kutanöz ilaç reaksiyonları, sık görülen hafif döküntülerden yaşamı tehdit eden ağır kutanöz advers reaksiyonlara kadar geniş bir klinik spektrum oluşturur. Bu bölümde advers ilaç reaksiyonlarının temel sınıflaması ve immünolojik mekanizmaları özetlenmekte; makülopapüler ilaç erüpsiyonu, ürtiker ve anjiyoödem, anafilaksi, fiks ilaç erüpsiyonu, akut generalize ekzantematöz püstüloz (AGEP), eozinofili ve sistemik semptomlarla seyreden ilaç reaksiyonu (DRESS), Stevens–Johnson sendromu/toksik epidermal nekroliz (SJS/TEN), ilaç ilişkili vaskülit, eritrodermi ve simetrik ilaç ilişkili intertriginöz ve fleksural ekzantem (SDRIFE) gibi başlıca klinik tablolar ele alınmaktadır. Ayrıca ilaç ilişkili fotosensitivite, saç dökülmesi, antikanser tedavilere bağlı kutanöz reaksiyonlar ve antikoagülanlara bağlı deri nekrozu kısaca gözden geçirilmektedir. Her klinik tablo için olası tetikleyiciler, tipik bulgular, tanısal yaklaşım, ayırıcı tanı, tedavi ve prognoz vurgulanmaktadır. Bölümün son kısmında, birinci basamakta izlenebilecek hastalar ile dermatoloji değerlendirmesi veya acil sevk gerektiren olgular ayırt edilmekte ve alarm bulgularına dikkat çekilmektedir.

25 September 2026
Verified
Book
Open access
PDF file
NMNurcan Metin
Nurcan Metin
RYRabia Yamak
Rabia Yamak
SBSanem Çolak Buzcu
Sanem Çolak Buzcu
TATunçay Ağkurt
Tunçay Ağkurt
MEMerve Hatun Erkayman
Merve Hatun Erkayman
ZUZeynep Karaca Ural
Zeynep Karaca Ural

7 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AMali osman Metintas
ali osman Metintas
HYHüseyin Yaman
Hüseyin Yaman
LSLeyla baykal selçuk
Leyla baykal selçuk
AFArzu Ferhatosmanoğlu
Arzu Ferhatosmanoğlu
MDMAHİR DIĞIŞ
MAHİR DIĞIŞ
ÖSÖmer FaruK Saz
Ömer FaruK Saz
Background/Objective: Psoriasis is a chronic immune-mediated inflammatory disease with systemic involvement. Immature granulocytes (IGs) are potential inflammatory markers, but their role in psoriasis is unclear. We evaluated immature granulocyte count (IG#) and percentage (IG%) in plaque psoriasis, their associations with disease severity and treatment response, and their ability to distinguish patients from healthy controls. Methods: This retrospective study included 85 adults with plaque psoriasis and 85 healthy controls. Severity was assessed by the Psoriasis Area and Severity Index (PASI). IG#, IG%, and inflammatory markers were measured before treatment and after at least 3 months of systemic therapy. Group comparisons, correlations, and receiver operating characteristic (ROC) analyses were performed. Results: Pre-treatment IG# and IG% were higher in patients than in controls (both p < 0.001). IG# decreased after treatment (p = 0.004), whereas IG% did not (p = 0.072). Despite clinical improvement, post-treatment IG#, IG%, and C-reactive protein remained higher than controls. Pre-treatment IG# correlated weakly with PASI (r = 0.24, p = 0.020), whereas other PASI–IG correlations were non-significant. Discriminatory performance was modest for IG# (AUC = 0.697) and IG% (AUC = 0.658). Conclusions: IG# and IG% are elevated in plaque psoriasis. IG# decreases with treatment and may be a potential marker of inflammatory changes, while the persistence of elevated IG# and IG% levels after treatment relative to healthy controls may reflect residual inflammation. However, weak associations with disease severity and modest discriminatory performance do not support their use as standalone clinical tools. As these parameters are routinely available from complete blood counts, they may complement clinical assessment. Further prospective studies are required to establish their clinical relevance.

31 January 2026 in Farabi Tıp Dergisi
Verified
Journal Article
Open access
AFArzu Ferhatosmanoğlu
Arzu Ferhatosmanoğlu
MBMojgan Zeynali Balestani
Mojgan Zeynali Balestani
ŞÇŞeyma Seray Çoban
Şeyma Seray Çoban
AMali osman Metintas
ali osman Metintas
LSLeyla baykal selçuk
Leyla baykal selçuk
DADeniz aksu arıca
Deniz aksu arıca
Objective: Demodex folliculorum and Demodex brevis are common components of the human cutaneous microbiome, and their pathogenic proliferation has been associated with several inflammatory facial dermatoses. Prolonged face mask use creates an occlusive microenvironment that may influence Demodex density; however, evidence on this association remains limited. This study aimed to evaluate the relationship between face mask use, Demodex infestation, facial symptoms, and skincare behaviors in adults. Material and Methods: This cross-sectional study included 287 adults attending a dermatology clinic. Participants completed a structured questionnaire on demographic characteristics, mask-wearing habits, skin symptoms, and skincare practices. Demodex density was assessed using standardized skin surface biopsy, and >5 mites/cm2 was considered positive. Results: Demodex infestation was detected in 7.6% of participants. Participants in the regular mask-use group (≥6 hours/day) had significantly lower infestation rates than those in the no-mask group (4.9% vs. 11.4%, p = .040). Individuals with Demodex infestation more frequently reported scaling (p = .012) and burning/tingling sensations (p = .006). Regular mask users reported higher moisturizer and facial cleanser use, which may contribute to reduced mite density. Gender distribution and dryness did not differ significantly between groups. Conclusion: Regular mask use was inversely associated with Demodex infestation, suggesting that mask-related changes in humidity, temperature, and hygiene routines may create an unfavorable microenvironment for mite survival. Scaling and burning/tingling emerged as meaningful clinical indicators of Demodex infestation. Behavioral and microenvironmental factors should be considered when evaluating patients with suspected Demodex-related symptoms. Prospective studies are warranted to elucidate underlying mechanisms.